CEL-SCI CORPORATION Commitments and Contingencies
CEL-SCI CORPORATION (CVM) had Commitments and Contingencies of $0 as of 2021-12-31, per its 10-Q filed 2022-02-11.
Discontinued › Balance Sheet › Liabilities
us-gaap:CommitmentsAndContingencies · last filed 2022-02-11
- 2021-12-31: Commitments and Contingencies $0.00.
- 2021-09-30: Commitments and Contingencies $0.00.
- 2021-03-31: Commitments and Contingencies $0.00.
- 2020-12-31: Commitments and Contingencies $0.00.
| Period end | Commitments and Contingencies |
|---|---|
| 2021-12-31 | $0.00 10-Q · filed 2022-02-11 |
| 2021-09-30 | $0.00 10-Q · filed 2022-02-11 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-17 |
| 2020-12-31 | $0.00 10-Q · filed 2021-02-12 |
| 2020-09-30 | $0.00 10-Q · filed 2021-02-12 |
| 2020-03-31 | $0.00 10-Q/A · filed 2020-12-30 |
| 2019-12-31 | $0.00 10-Q/A · filed 2020-12-30 |
| 2019-09-30 | $0.00 10-Q/A · filed 2020-12-30 |
| 2014-09-30 | $0.00 10-K · filed 2014-12-23 |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-08 |
| 2013-12-31 | $0.00 10-Q · filed 2014-02-10 |
| 2013-09-30 | $0.00 10-K · filed 2014-12-23 |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-09 |
| 2011-09-30 | $0.00 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |